This dataset was taken from the list of OpenIntro dataset files found at https://www.openintro.org/data/.
OpenIntro features a number of free books that can be used in high school and AP statistics courses. The license on these datasets is currently unknown. You can find out more about OpenIntro at https://www.openintro.org.
Three treatments were compared to test their relative efficacy(effectiveness) in treating Type 2 Diabetes in patients aged 10-17 who werebeing treated with metformin. The primary outcome was lack of glycemiccontrol (or not); lacking glycemic control means the patient still neededinsulin, which is not the preferred outcome for a patient.
- treatment - The treatment the patient received.
- outcome - Whether there patient still needs insulin (failure) or met a basic positive outcome bar (success).
Zeitler P, et al. 2012. A Clinical Trial to Maintain GlycemicControl in Youth with Type 2 Diabetes. N Engl J Med.
Each of the 699 patients in the experiment were randomized to one of thefollowing treatments: (1) continued treatment with metformin(coded as met), (2) formin combined with rosiglitazone (coded asrosi), or or (3) a lifestyle-intervention program (coded aslifestyle).
Taken from: https://www.openintro.org/data/index.php?data=diabetes2.